Komori
Vital Ksk Holdings (3151) · InitiativeAdvanced

Enhancing Business Value Through the Reorganization of the Pharmacy Business

First written in FY2019-Q1. 3 of 8 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2026.

8entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q3 – FY2019RaisedFY2021 – FY20262018: 220182019: 220192020: 020202021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies

27 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 79 companies compared. The sentences above are computed from all 79.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「② Pharmacy business segment: The company will pursue the following practical initiatives to achieve ROIC above the hurdle rate: 1) integration of the management of consolidated and non-consolidated subsidiaries; 2) improving ROIC by eliminating excess capital; and 3) opening new stores and pursuing M&A.」

    The company is translating the enhancement of pharmacy business value into specific initiatives involving ROIC, subsidiary integration, elimination of excess capital, and new store openings and M&A.
  2. FY2025AdvancedAnnual report

    「② Pharmacy business segment: The company will pursue the following practical initiatives to achieve ROIC above the hurdle rate: 1) integration of the management of consolidated and non-consolidated subsidiaries; 2) improving ROIC by eliminating excess capital; and 3) opening new stores and pursuing M&A.」

    The restructuring and value enhancement of the pharmacy business have been translated into specific initiatives: subsidiary management integration, elimination of excess capital, new store openings and M&A, and ROIC improvement.
  3. FY2022RaisedAnnual report

    「In our group's pharmacy business, which has grown to nearly 100 stores, we will promote the development of a supply chain made possible by being a pharmacy group operated by a pharmaceutical wholesaler.」

    The pharmacy business has reached a scale of nearly 100 stores, and the company is expanding its initiatives to develop a supply chain aimed at increasing business value following the restructuring.
  4. FY2021RaisedAnnual report

    「In our group's pharmacy business, which has grown to nearly 100 stores, we will promote the development of a supply chain made possible by being a pharmacy group operated by a pharmaceutical wholesaler.」

    The pharmacy business has reached a scale of approximately 100 stores, expanding the scope and scale of the target for increasing business value following the restructuring.
  5. FY2019RestatedAnnual report

    「In July 2018, we restructured the pharmacy business of our group and are working to increase its business value.」

    The company continues to work to increase business value following the restructuring of the pharmacy business carried out in July 2018.
  6. FY2019-Q3RestatedAnnual report

    「In July 2018, we restructured the pharmacy business of our group and are working to increase its business value.」

    The company has reaffirmed its policy of working to increase business value following the restructuring of the pharmacy business carried out in July 2018.
  7. FY2019-Q2AdvancedAnnual report

    「In July 2018, we restructured the pharmacy business of our group and are working to increase its business value.」

    The company states that it carried out the pharmacy business restructuring planned for July 2018 and has moved on to the stage of increasing business value following the restructuring.
  8. FY2019-Q1First statedAnnual report

    「In July 2018, we restructured the pharmacy business of our group and will work to increase its business value.」

    The company newly states that it restructured the group's pharmacy business in July 2018 and plans to increase its business value.
Moved together

"Shareholdings to Strengthen Business Relationships" moved the same way as this thread, in the same document, in 4 of its 8 moves.

443322★123456
  1. ★This thread
  2. 1Shareholdings to Strengthen Business Relationships4×
  3. 2Shareholder returns through share repurchases4×
  4. 3Strengthening High-Value-Added Logistics Functions and Disaster Response Capabilities3×
  5. 4Planned annual dividend of ¥20 per share for the following fiscal year3×
  6. 5Focus on products eligible for the premium for promoting new drug development and addressing off-label drug use, as well as new products2×
  7. 6Strengthening Corporate Governance2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Vital Ksk Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Business Value Through the Reorganization of the Pharmacy Business | VITAL KSK HOLDINGS,INC. (3151) | Komori